image

MS Matters: Are current measures of disability progression good enough?

Location Webinar
Date 10.12.2018 10:00 - 10.12.2018 11:00

Understanding EDSS

In this first CONy & Teva Neuroscience MS Matters webinar series, Prof. Sven Schippling and Prof. Gavin Giovannoni discuss the EDSS tool as a measure of disability progression in MS and whether it is fit for purpose.

Beyond EDSS

Continuing with the first CONy & Teva Neuroscience MS Matters webinar entitled MS Matters: Are current measures of disability progression good enough, Prof. Sven Schippling and Prof. Gavin Giovannoni discuss alternative tools to measure disability progression in MS.

Assessing disability progression – a patient's perspective

Listen to the patient’s perspective on the relevance of EDSS in assessing the progression of their disease and which symptoms should be adequately captured in the future.

Future perspectives

Prof. Sven Schippling highlights the key messages from the CONy & Teva Neuroscience MS Matters webinar entitled MS Matters: Are current measures of disability progression good enough and give his insights into how disability progression should be measured in the future.

Faculty:

Prof. Sven Schippling (Moderator), University Hospital Zürich, Switzerland

Prof. Gavin Giovannoni, Blizard Institute, Barts and The London School of Medicine and Dentistry, UK

Patient contributor, London, UK